InvestorsHub Logo
icon url

roiresearch

12/31/20 2:45 PM

#338457 RE: JTORENCE #338446

other then the headline by a 3rd party, i am having a hard time finding where Russia says they developed it. 50/50 chance it is Brilacidin. The timeline fits with the CTA and all the pre-clinical data released by GMU

At no point does it say it's been tested in humans

As much as I would love to have more concrete info on anything P2 related, I will grasp at this straw in the meanwhile

happy and healthy